The SCENIHR undertook a public consultation on the basis of an opinion adopted on 28-29 September 2005 on the Safety of Human-derived Products with regard to Variant Creutzfeldt-Jakob Disease. Interested parties were invited to submit comments and pertinent scientific information by e-mail by 10 February 2006.
Following comments from the public consultation the opinion was modified and adopted by the SCENIHR during the 11th plenary meeting of 11-12 May 2006.
The Synthesis Report presents the overall results from the public consultation including the SCENIHR responses.
The following public comments were received by the SCENIHR.